MEDICUS PHARMA LTD. Payments of Stock Issuance Costs
MEDICUS PHARMA LTD. (MDCX) reported Payments of Stock Issuance Costs of $653.50 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-25
- MEDICUS PHARMA LTD. payments of stock issuance costs for the quarter ending 2025-12-31 was $69.14K.
- MEDICUS PHARMA LTD. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00.
- MEDICUS PHARMA LTD. payments of stock issuance costs for fiscal 2025 was $653.50K.
- MEDICUS PHARMA LTD. payments of stock issuance costs for fiscal 2024 was $0.00.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2025-12-31 | $69.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $653.50K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $584.36K 10-Q · filed 2025-11-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |